Ireland· IE-PA-EU/1/09/533/1-3
Vedrop 50 mg/ml Oral solution
A tocofersolan product containing tocofersolan d-alpha tocopheryl polyethylene glycol 1000 succinate, registered in Ireland by Recordati Rare Diseases. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tocofersolan is registered in 11 of 19 countries.
Countries holding a registration under ATC A11HA08 (tocofersolan), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Tocofersolan · ATC A11HA08
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Tocofersolan d-alpha tocopheryl polyethylene glycol 1000 succinate
- Manufacturer
- Recordati Rare Diseases
- Country
- Ireland (IE)
- ATC code
- A11HA08
- ATC class
- Tocofersolan
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/09/533/1-3
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tocofersolan in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVEDROPRecordati Rare Diseases, Puteaux
- FinlandVedropRecordati Rare Diseases
- FranceVEDROP 50 mg/ml, solution buvableRECORDATI RARE DISEASES
- IcelandVedropRecordati Rare Diseases*
- PolandVedropRecordati Rare Diseases
- SpainVEDROP 50 MG/ML EN SOLUCION ORALRecordati Rare Diseases
- United KingdomVedrop 50mg/ml oral solutionRecordati Rare Diseases UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/29b99714-4f2e-4ce6-8d8e-232bd98f7d97 GET /v1/drugs/29b99714-4f2e-4ce6-8d8e-232bd98f7d97?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A11HA08"
],
"strength": null,
"pa_number": "EU/1/09/533/1-3",
"substances": [
"Tocofersolan d-alpha tocopheryl polyethylene glycol 1000 succinate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tocofersolan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.